Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

CDC Advocates All-IPV Immunization Schedule; Combo Development Heats Up

  • News

Executive Summary

The move to a CDC-recommended all-IPV dosing schedule will create shifts in the multi-component pediatric vaccine market as well as support for Pasteur Merieux Connaught's inactivated polio vaccine.

You may also be interested in...



Medco Suits Complicate Merck Spin-Off Plans, Position In Medicare Debate

The unsealing of two "whistleblower" complaints filed against Medco Health Solutions is the latest complication in Merck's plans to spin-off the pharmacy benefit management division

Merck-Medco Las Vegas Pharmacy Is At Center Of “Whistleblower” Case

Merck's ownership of Medco has resulted in a significant decline in sound pharmacy practices at the PBM's mail order facilities, two ex-employees charge in a "whistleblower" suit unsealed June 23

Medco Suits Complicate Merck Spin-Off Plans, Position In Medicare Debate

The unsealing of two "whistleblower" complaints filed against Medco Health Solutions is the latest complication in Merck's plans to spin-off the pharmacy benefit management division

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Tags:
Latest Headlines

‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs

National Drug Stockpiles Create ‘False Sense Of Security’

Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests

Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs

See All
UsernamePublicRestriction

Register

PS034391

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By